Nuveen Asset Management, LLC Supernus Pharmaceuticals, Inc. Transaction History
Nuveen Asset Management, LLC
- $329 Billion
- Q1 2024
A detailed history of Nuveen Asset Management, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 227,032 shares of SUPN stock, worth $5.85 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
227,032
Previous 130,731
73.66%
Holding current value
$5.85 Million
Previous $3.78 Million
104.71%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding SUPN
# of Institutions
260Shares Held
57.3MCall Options Held
84.1KPut Options Held
61.2K-
Black Rock Inc. New York, NY10.4MShares$267 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.21MShares$160 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY3.57MShares$92.1 Million1.66% of portfolio
-
Macquarie Group LTD Australia, C32.67MShares$68.8 Million0.1% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.56MShares$65.9 Million0.02% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.38B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...